1. Home
  2. Cannabis

Cannabis

Weed and gold, the unloved investment thematics

Next Investors Oct 22, 2022

We have all seen when a new investment theme goes through an initial period of hype, the peak of inflated expectations and then the trough of disillusionment. Today we will look at how this hype cycles affects to investment themes we are closely watching for 2023: Weed and Gold

Bod Australia outlines strong revenue growth

Finfeed Archived Apr 22, 2021

Medicinal cannabis, CBD and hemp healthcare products company, Bod Australia Limited (ASX: BDA) has provided its shareholders an update for the Q3FY2021 quarter, ended 31 March 2021.

Move to legalisation of psychedelics could benefit CPH in the US

Finfeed Archived Apr 19, 2021

Creso Pharma Limited’s (ASX:CPH, FRA:1X8) target acquisition company Halucencex Life Sciences Inc. has signed a non-binding Letter of Intent (LOI) with leading nanotechnology company Sixth Wave Inc. as California pushes to decriminalise psychedelics, which highlights the ongoing acceptance and regulatory shift towards psychedelics as an alternative treatment route for debilitating mental health conditions.

Creso Pharma’s target acquisition company announces expansion into other psychedelic compounds

Finfeed Archived Apr 12, 2021

Creso Pharma Limited (ASX: CPH, FRA:1X8) has provided an update regarding target acquisition company, Halucenex Life Sciences, outlining its entry into an advisory agreement with Growing Together Research Inc. (GTR) to explore the genome sequencing of natural psilocybe.

CPH looks to expand its footprint as NY State reaches deal legalise recreational cannabis

Finfeed Archived Apr 06, 2021

Creso Pharma (ASX: CPH) has appointed a US Director of Business Development just as New York State has legalised recreational cannabis. New York State is expected to become one of the largest recreational markets in the US valued at US$4.2BN.

Revenue generating BDA sets its sights on US market

Finfeed Archived Mar 17, 2021

Bod Australia (ASX: BDA) is a cannabis centric healthcare company, with well-branded premium, proven and trusted products within two distinct verticals: Medical Cannabis and CBD and Hemp Consumer products.

Neurotech to commence clinical study program this quarter

Finfeed Archived Feb 15, 2021

Following the successful in vitro findings, Neurotech (ASX: NTI) has begun designing a phase I/II study to assess the safety and efficacy of the novel NTI/Dolce strain in a paediatric population.

Creso Pharma leads the way in burgeoning cannabis market

Finfeed Archived Jan 29, 2021

Creso Pharma looks set to start the year on a strong note after an impressive performance in the December quarter of 2020

Canopy Growth Founder Joins a Refreshed, Re-Set and Re-Funded CPH

Next Investors Archived Oct 13, 2020

While Creso Pharma (ASX: CPH) continues to sign purchase orders and has appointed Bruce Linton as an advisor, it is a highly speculative investment, and our intent is to hold for the coming months through to Christmas to see how the company’s strategy plays out.

What does a Kamala Harris Vice Presidency mean for cannabis legalisation?

Finfeed Archived Aug 31, 2020

Joe Biden announced that Kamala Harris is his pick for Vice President, should he win the upcoming US Presidential election in November. But what could a Biden/Harris ticket mean for cannabis legalization?

Embark Health continues to deliver for MMJ Group

Finfeed Archived Jun 01, 2020

MMJ Group Holdings Limited (ASX:MMJ; OTC:MMJJF) was a foundation investor in Embark Health, which has now commenced production of bubble hash, rosin and dry sift.

How (and why) companies are mixing Terpenes into Cannabis Distillates

Finfeed Archived May 29, 2020

Cannabis enthusiasts purchase terps and incorporate them into everything from homemade brownies to vape juice. But there’s one industry that’s had surprisingly less of a symbiotic relationship with terpenes than anyone might have expected; namely the cannabis industry.

Cannabis companies unite to help combat COVID-19

Finfeed Archived Apr 28, 2020

Canada’s WeedMD is pivoting to help the broader health sector as COVID-19 continues to put lives in danger.

MMJ increases stake in Sequoya

Finfeed Archived Apr 16, 2020

MMJ Group Holdings Limited (ASX: MMJ/OTC: MMJJF) has agreed to provide a C$2.5 million secured convertible note facility to Sequoya Cannabis Limited.

Would the legalisation of recreational cannabis fill a budget black hole?

Finfeed Archived Apr 03, 2020

Federal or State governments could consider legalising recreational cannabis to fill the budget black holes they will face post the COVID-19 pandemic.

COVID-19 boosts cannabis sales by 159%

Finfeed Archived Mar 27, 2020

Reports show that anxiety-driven consumers are now stockpiling cannabis in at least four US states thanks to COVID-19.

Could This ASX Cannabis Stock Soar Amid the Coronavirus?

Finfeed Archived Mar 20, 2020

As fears surrounding the Coronavirus drive the markets down, one ASX-listed pot stock could triumph amid the COVID-19 crisis.

Can cannabis companies rebound after COVID-19?

Finfeed Archived Mar 17, 2020

Will cannabis stocks survive the Coronavirus? The strong will survive and there could be bargains to be had.
Page 1 of 7 next >

Get Expert Stock
Analysis and Opinions

Join thousands of other Investors following our stock commentary for Free

X